Skip to main content
BioMed Research International logoLink to BioMed Research International
. 2021 Apr 12;2021:9824165. doi: 10.1155/2021/9824165

Corrigendum to “The Antiosteoporosis Effects of Yishen Bugu Ye Based on Its Regulation on the Differentiation of Osteoblast and Osteoclast”

Yangyang Li 1, Yongfeng Zhang 2, Weiqi Meng 2, Yutong Li 1, Tao Huang 3, Di Wang 2,, Min Hu 1,
PMCID: PMC8068548  PMID: 33954203

In the article titled “The Antiosteoporosis Effects of Yishen Bugu Ye Based on Its Regulation on the Differentiation of Osteoblast and Osteoclast” [1], the authors identified a mistake in Figure 1, where panel 2 of the liver samples was duplicated with panel 6. The authors confirm that this does not affect the results and conclusions of the article, and the corrected Figure 1 is as follows:

Figure 1.

Figure 1

Effects of YSBGY on the structures of the liver, spleen, and kidney of OP mice visualized by H&E staining (n = 6; 200x, scale bar: 50 μm).

Contributor Information

Di Wang, Email: jluwangdi@jlu.edu.cn.

Min Hu, Email: humin@jlu.edu.cn.

References

  • 1.Li Y., Zhang Y., Meng W., et al. The Antiosteoporosis Effects of Yishen Bugu Ye Based on Its Regulation on the Differentiation of Osteoblast and Osteoclast. BioMed Research International. 2020;2020:12. doi: 10.1155/2020/9467683.9467683 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BioMed Research International are provided here courtesy of Wiley

RESOURCES